Dr. Reddy’s Lab profit up 18 %

May 14, 2013 11:25 pm | Updated 11:25 pm IST - HYDERABAD:

Dr. Reddy’s Laboratories (DRL), on Tuesday, reported a 66.58 per cent increase in net profit to Rs.570.9 crore for the fourth quarter of 2012-13 from Rs.342.7 crore in the previous year, due to healthy sales from North America and emerging markets in the company’s global generics segment, apart from improved performance in the pharma services and active ingredients (PSAI) segment.

For 2012-13, DRL’s consolidated net profit was Rs.1,677.6 crore, up 17.62 per cent from Rs.1,426 crore. Revenues were estimated at Rs.11,626.6 crore against Rs.9,673.7 crore, up 20.18 per cent. Revenues from the global general segment were Rs.8.260 crore, a growth of 18 per cent year-on-year.

Dividend

The board of directors has recommended a final dividend of Rs.15 per share of Rs.5 face value for 2012-13. A dividend of Rs.13.75 per share was paid for 2011-12.

The growth in North America was largely driven by key limited competition products such as ziprasidone, fondaparinux and the ramp-up of the antibiotics portfolio and products from the Shreveport, U.S. facility, said K. Satish Reddy, Vice-Chairman and Managing Director said while announcing the results at a press conference here.

The company was looking at dosage forms such as ‘injectables’ to grow in the North America market, a geography where OTC (over-the-counter) too was a big segment that would witness continued investment of resources, said Chairman, G. V. Prasad.

He said they were garnering OTC revenues from India too, but on a different scale. At present, OTC sale contributed 34 per cent of the company’s annual sales.

Mr. Prasad said the company collaborated with Merck Serono, part of the Germany-based Merch KGaA, for developing and commercialising ‘bio-similars’ last year.

Rs.7.40 dividend from Reliance Infra

Reliance Infrastructure has reported a consolidated net profit of Rs.725 crore for the quarter ended March 31, 2013, against Rs.411 crore in the corresponding quarter of the previous year, up 76 per cent.

Total operating income was down at Rs.6,187 crore against Rs.7,135 crore.

For the whole of 2012-13, the company reported a consolidated net profit of Rs.2,247 crore against Rs.1,587 crore in the previous year, up 42 per cent. Cash profit increased by 24 per cent to Rs.2,912 crore from Rs.2,342 crore. Total operating income was down at Rs.22,382 crore against Rs.24,216 crore.

The board has recommended dividend of Rs.7.40 per share for 2012-13.

On a standalone basis, Reliance Infrastructure has reported a lower net profit Rs.599 crore for the fourth quarter ended March 31, 2013, as compared to Rs.658 crore in the corresponding quarter of the previous year.

For the year ended March 31, 2013, its standalone net profit has come down to Rs.1,999.52 crore from Rs.2000.26 crore in the previous year.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.